Brief: Corline Biomedical Q3 Loss After Financial Items Narrows To SEK 2.1 Mln
Nov 25 (Reuters) - Corline Biomedical AB CLBIO.ST :
* CORLINE BIOMEDICAL AB - Q3 NET SALES AMOUNTED TO SEK 962
THOUSAND (368)
* CORLINE BIOMEDICAL AB - Q3 PROFIT AFTER FINANCIAL ITEMS
AMOUNTED
TO SEK -2,075 THOUSAND (-2 150)
Source text for Eikon: ID:nGNE84XgvK
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln